On December 19, 2023, ImpriMed, Inc. closed the transaction. The company raised $20,000,000 in its second tranche, bringing the total fund raised to $23,000,000 in the transaction led by a new investor SoftBank Ventures Asia Co., Ltd.. The transaction included participation from new investors SK Telecom Co., Ltd. (KOSE:A017670), Byucksan Corporation (KOSE:A007210), Samyang Chemical Ind.

Ltd., KDB Silicon Valley LLC, Ignite Innovation Fund, Han River Zium Development Llc, and returning investor Murex Partners LLC.